Acknowledgements
Wieland-Alter
MOORE
The authors are grateful to all the participants who volunteered for this study. We thank Drs. Ananda Bandyopadhyay and John Modlin from BMGF for technical inputs in designing the clinical study and the late Dr. Marc Collett who shared data and expertise that greatly assisted the research. We also thank Drs. Marcela Pasetti, Wendy Wieland-Alter and Joshua Weiner for their scientific support during various stages of the research, and Véronique Olislagers and Ines Vu Duc for expert technical assistance. GlaxoSmithKline Biologicals SA (GSK, Rixensart, Belgium) generously provided the bOPV and was provided with the opportunity to review a preliminary version of this manuscript for factual accuracy, but the authors are solely responsible for final content and interpretation. This activity was reviewed by CDC and was conducted consistent with applicable federal law and CDC policy.§ See e.g., 45 C.F.R. part 46, 21 C.F.R. part 56; 42 U.S.C. §241(d); 5 U.S.C. §552a; 44 U.S.C. §3501 et seq.). We thank the staff at the CDC for performing the neutralizing antibody assays (William Hendley, Kathryn Jones, Sharla McDonald, Deborah Moore, Mario Nicolas, and Yiting Zhang) and the detection and measurement of poliovirus in fecal samples (Ray Campagnoli, Elizabeth Coffee, Larin McDuffie, Jing Shaw, and Ling Wei). Keith Veitch (keithveitch communications, Amsterdam, the Netherlands) provided writing and editorial support with the manuscript.
The data presented in this study will be made available upon appropriate request to the Corresponding author.